
Andrew Craig
Ex-investment banker, founder of Plain English Finance, and author of personal finance books. Offers insights into finance and investing.
Top 3 podcasts with Andrew Craig
Ranked by the Snipd community

12 snips
Oct 30, 2024 • 1h 10min
Why is Britain in such a state? Plain English answers and solutions with Andrew Craig
Join Andrew Craig, author and founder of Plain English Finance, as he dives into the current state of Britain's economy. He highlights how poor regulations have hampered growth, particularly in the stock market. Craig emphasizes the pressing need for improved financial literacy to empower investors and calls for a reevaluation of policies affecting the biotech sector. The conversation also touches on the allure of quick riches, the role of immigration in economic narratives, and the bright future of personalized health investments.

5 snips
Aug 13, 2023 • 1h 33min
200) Andrew Craig - The Truth About Your Financial Future
In this illuminating conversation, Andrew Craig, an ex-investment banker and founder of Plain English Finance, shares his insights on navigating today’s economic landscape. He discusses inflation manipulation and the challenges facing investors, emphasizing the positive potential of capitalism and biotechnology. Andrew provides a fresh perspective on cryptocurrency as a speculative venture, while promoting disciplined financial habits for long-term success. His journey into self-employment also inspires listeners to pursue their passions actively.

Nov 4, 2024 • 1h 9min
The hidden crisis in the UK economy
Join Andrew Craig, author and founder of Plain English Finance, as he unveils the hidden crises in the UK economy. He discusses the alarming decline in stock market value and the need for financial literacy to support local businesses. Explore the promising future of biotechnology and its potential to reshape industries while addressing pressing global challenges. Craig also highlights the struggle of small businesses with cash management and urges a focus on investing in undervalued biotech firms to revitalize the economy.